UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000037062
Receipt No. R000042198
Scientific Title Study on evaluation of reduction effect of test supplement on body fat -a randomized, double blind, placebo controlled, parallel group comparison study-
Date of disclosure of the study information 2019/06/14
Last modified on 2020/06/12 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Study on evaluation of reduction effect of test supplement on body fat -a randomized, double blind, placebo controlled, parallel group comparison study-
Acronym Body fat reduction effect of test supplement
Scientific Title Study on evaluation of reduction effect of test supplement on body fat -a randomized, double blind, placebo controlled, parallel group comparison study-
Scientific Title:Acronym Body fat reduction effect of test supplement
Region
Japan

Condition
Condition Healthy subject
Classification by specialty
Not applicable Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 This study aimed to assess the effect of test supplement on body fat.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Abdominal visceral fat area
Key secondary outcomes Abdominal total fat area, abdominal subcutaneous fat area, body weight, BMI, waist circumference, hip circumference, ratio of waist and hip circumferences, subgroup analysis (BMI, abdominal visceral fat area, sex, defecation frequency)

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification NO
Dynamic allocation NO
Institution consideration Institution is not considered as adjustment factor.
Blocking NO
Concealment No need to know

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Food
Interventions/Control_1 Intake of test supplement for 12 consecutive weeks
Interventions/Control_2 Intake of placebo for 12 consecutive weeks
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
45 years-old <=
Age-upper limit
70 years-old >
Gender Male and Female
Key inclusion criteria 1. Japanese male and female whose age is between 45 and 70 years old
2. Subjects whose BMI is between 23 and 30
Key exclusion criteria 1. Subjects who are currently under medical treatment, diet therapy or exercise therapy.
2. Subjects who are under treatment or have a history of serious disease(e.g., diabetes, liver disease, kidney disease, or heart disease, abnormal secretion disease of adrenocortical hormone)
3. Subjects with allergies to the test food in this study
4. Females who are known or suspected to be pregnant, breastfeeding or desire to become pregnant during the trial period.
5. Subjects who routinely use some medicine, health foods affecting body fat or lipid metabolism.
6. Subjects who currently are dieting.
7. Subjects who have participated in other clinical study within the past month prior.
8. Subjects who use some medicine, food containing lactic acid bacteria or polymethoxyflavone 3 days a week or more from half a year before the informed consent.
9. Subjects who are judges as unsuitable for the study based on the results of lifestyle questionnaire
10. Subjects who are judged as unsuitable for the study based on the results of clinical laboratory test or cardiopulmonary function.
11. Subjects who have diseases requiring continuous medication, or serious medical history who needed medication therapy
12. Subjects who always use laxative when defecation.
13. Subjects who have taken antibiotics within the past month
14. Subjects who are judged as unsuitable for the study based on the results of clinical laboratory test or physical examination.
15. Subjects who are planning to travel abroad during the study period, or who are planning of long term domestic trip for more than one week in study period.
16. Subjects who are judged as unsuitable for the study by the investigator for other reason
Target sample size 100

Research contact person
Name of lead principal investigator
1st name Kei
Middle name
Last name Yui
Organization FANCL Corporation
Division name Research Institute, Health science research center
Zip code 244-0806
Address 12-13, Kamishinano, Totsuka-ku, Yokohama, Kanagawa
TEL 045-820-3755
Email ke-yui@fancl.co.jp

Public contact
Name of contact person
1st name Shingo
Middle name
Last name Yamamichi
Organization TTC Co., Ltd.
Division name Clinical Research Planning Department
Zip code 150-0021
Address 1-20-2, Ebisu-nishi, Shibuya-ku, Tokyo, Japan
TEL 03-5459-5329
Homepage URL
Email s.yamamichi@ttc-tokyo.co.jp

Sponsor
Institute TTC Co., Ltd.
Institute
Department

Funding Source
Organization FANCL Corporation
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Aisei Hospital Ueno Clinic Research Ethics Committee
Address 2-18-6, Higashiueno, Taitou-ku, Tokyo
Tel 03-6455-0880
Email t.saito@ttc-smo.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2019 Year 06 Month 14 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 104
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2019 Year 06 Month 13 Day
Date of IRB
2019 Year 06 Month 14 Day
Anticipated trial start date
2019 Year 06 Month 14 Day
Last follow-up date
2019 Year 12 Month 01 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2019 Year 06 Month 13 Day
Last modified on
2020 Year 06 Month 12 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042198